Clinical trial
A Single Arm Phase II Study of Neoadjuvant Therapy Using Irinotecan Bead in Patients With Resectable Liver Metastases From Colorectal Cancer
NCT00844233 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Arm Phase II Study of Neoadjuvant Therapy Using Irinotecan Bead in Patients With Resectable Liver Metastases From Colorectal Cancer
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- October 31, 2012
- Enrollment
- 40 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic colorectal cancer